A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
D000741:Anemia, Aplastic / Q000378:metabolism / Q000473:pathology; D001853:Bone Marrow / Q000473:pathology*; D018958:CD55 Antigens / Q000378:metabolism; D018957:CD59 Antigens / Q000378:metabolism; D002999:Clone Cells / Q000473:pathology; D003165:Complement System Proteins / Q000502:physiology; D017261:Glycosylphosphatidylinositols / Q000172:deficiency / Q000502:physiology; D006410:Hematopoiesis; D006457:Hemoglobinuria, Paroxysmal / Q000209:etiology* / Q000235:genetics / Q000276:immunology / Q000473:pathology; D006801:Humans; D008565:Membrane Proteins / Q000172:deficiency / Q000235:genetics; D008954:Models, Biological; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000378:metabolism / Q000473:pathology; D010198:Pancytopenia / Q000209:etiology / Q000473:pathology; D011289:Preleukemia / Q000235:genetics / Q000473:pathology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D025721:WT1 Proteins / Q000502:physiology
D018958:CD55 Antigens; D018957:CD59 Antigens; D017261:Glycosylphosphatidylinositols; D008565:Membrane Proteins; D025721:WT1 Proteins; C080086:phosphatidylinositol glycan-class A protein; D003165:Complement System Proteins